SEC 13F Intelligence

Managers / Q3 2020 · view latest →

CAPSTONE INVESTMENT ADVISORS, LLC

CIK 0001426196 · 7 WORLD TRADE CENTER, 250 GREENWICH STREET, 32ND FLOOR, NEW YORK, NY, 10007 · (212) 232-1420

Reported Value
$19.6B
Q3 2020
Positions
1,384
Filings on Record
40
2019–present window
Filed
Nov 16, 2020
original filing

Summary

Capstone Investment Advisors, LLC reported $19.6B in U.S.-listed holdings across 1,384 positions for Q3 2020.

Its largest position, Spdr S P 500 Etf Tr, represents 3.3% of the portfolio.

Compared with Q2 2020, the fund opened 66 new positions and exited 46.

Portfolio Metrics

Turnover
+7.4%
vs prior filed quarter
Largest Position
+3.3%
Spdr S P 500 Etf Tr
New / Exited
66 / 46
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $8.1BQ4 ’18Q1 ’19: $10.9BQ2 ’19: $10.9BQ3 ’19: $14.6BQ4 ’19: $18.5BQ4 ’19Q1 ’20: $6.2BQ2 ’20: $15.1BQ3 ’20: $19.6BQ4 ’20: $29.9BQ4 ’20Q1 ’21: $34.1BQ2 ’21: $44.0BQ3 ’21: $50.5BQ4 ’21: $59.8BQ4 ’21Q1 ’22: $36.4BQ2 ’22: $20.5BQ3 ’22: $16.6BQ4 ’22: $13.7BQ4 ’22Q1 ’23: $19.8BQ2 ’23: $20.2BQ3 ’23: $22.2BQ4 ’23: $33.2BQ4 ’23Q1 ’24: $27.8BQ2 ’24: $31.9BQ3 ’24: $32.9BQ4 ’24: $41.4BQ4 ’24Q1 ’25: $37.8BQ2 ’25: $40.4BQ3 ’25: $53.7BQ4 ’25: $51.1BQ4 ’25Q1 ’26: $57.4Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 78.9%ETP: 14.2%US DOMESTIC: 2.8%Other: 2.4%REIT: 1.2%Other: 0.4%
  • Common Stock · 78.9% · $15.4B
  • ETP · 14.2% · $2.8B
  • US DOMESTIC · 2.8% · $542M
  • Other · 2.4% · $478M
  • REIT · 1.2% · $243M
  • Other · 0.4% · $83M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
IMMUIMMUNOMEDICS INCNEW+851.8K851.8K+$72M$72M
CHINA BIOLOGIC PRODS HLDGS INEW+500.2K500.2K+$56M$56M
MNTAMOMENTA PHARMACEUTICALS INCNEW+453.4K453.4K+$24M$24M
CACCCREDIT ACCEP CORP MICHNEW+68.7K68.7K+$23M$23M
TDOCTELADOC HEALTH INCNEW+98.1K98.1K+$21M$21M
DOCUDOCUSIGN INCNEW+67.7K67.7K+$15M$15M
ISHARES TRNEW+123.4K123.4K+$14M$14M
APELLIS PHARMACEUTICALS INCNEW+12.00M12.00M+$13M$13M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2020

4 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1SPDR S&P 500 ETF TRTR UNIT3.27%$640M1.91M
2TESLA INCNOTE 2.000% 5/10.48%$93M13.50M
3TIFEURTIFFANY & CO NEWhistory →COM0.47%$92M792.8K
4IMMUIMMUNOMEDICS INChistory →COM0.37%$72M850.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$57.4B1,558May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$51.1B1,530Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$53.7B1,889Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$40.4B1,556Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$37.8B1,317May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$41.4B1,824Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$32.9B1,886Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$31.9B2,031Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$27.8B2,306May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$33.2B2,073Feb 12, 202413F-HRchanges · EDGAR ↗
Q3 2023$22.2B2,081Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$20.2B1,824Aug 10, 202313F-HRchanges · EDGAR ↗
Q1 2023$19.8B1,542May 9, 202313F-HRchanges · EDGAR ↗
Q4 2022$13.7B1,493Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$16.6B1,642Nov 10, 202213F-HRchanges · EDGAR ↗
Q2 2022$20.5B1,805Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$36.4B2,076May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$59.8B1,848Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$50.5B1,999Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$44.0B1,599Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$34.1B1,616May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$29.9B1,658Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$19.6B1,384Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$15.1B1,306Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$6.2B1,107May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$18.5B1,375Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$14.6B1,342Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$10.9B1,282Aug 15, 2019RESTATEMENTchanges · EDGAR ↗
Q1 2019$10.9B1,146May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$8.1B1,239Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.